참고문헌 (47)

1. J Am Soc Nephrol Q Cao 21 933 2010 10.1681/ASN.2009060592 Cao Q, Wang Y, Zheng D, Sun Y, Lee VW, Zheng G, Tan TK, Ince J, Alexander SI, Harris DC (2010) IL-10/TGF-beta-modified macrophages induce regulatory T cells and protect against adriamycin nephrosis. J Am Soc Nephrol 21:933-942 

   상세보기

2. Pharm Res JA Champion 25 1815 2008 10.1007/s11095-008-9562-y Champion JA, Walker A, Mitragotri S (2008) Role of particle size in phagocytosis of polymeric microspheres. Pharm Res 25:1815-1821 

   상세보기

3. Small AS Cheung 12 2321 2016 10.1002/smll.201600061 Cheung AS, Koshy ST, Stafford AG, Bastings MM, Mooney DJ (2016) Adjuvant-loaded subcellular vesicles derived from disrupted cancer cells for cancer vaccination. Small 12:2321-2333 

   상세보기

4. J Control Release LJ Cruz 192 209 2014 10.1016/j.jconrel.2014.07.040 Cruz LJ, Rosalia RA, Kleinovink JW, Rueda F, Lowik CW, Ossendorp F (2014) Targeting nanoparticles to CD40, DEC-205 or CD11c molecules on dendritic cells for efficient CD8(+) T cell response: a comparative study. J Control Release 192:209-218 

   상세보기

5. Proc Natl Acad Sci USA MA Curran 107 4275 2010 10.1073/pnas.0915174107 Curran MA, Montalvo W, Yagita H, Allison JP (2010) PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors. Proc Natl Acad Sci USA 107:4275-4280 

   상세보기

6. Cancer Res SJ Dovedi 74 5458 2014 10.1158/0008-5472.CAN-14-1258 Dovedi SJ, Adlard AL, Lipowska-Bhalla G, McKenna C, Jones S, Cheadle EJ, Stratford IJ, Poon E, Morrow M, Stewart R, Jones H, Wilkinson RW, Honeychurch J, Illidge TM (2014) Acquired resistance to fractionated radiotherapy can be overcome by concurrent PD-L1 blockade. Cancer Res 74:5458-5468 

   상세보기

7. Proc Natl Acad Sci USA SE Gratton 105 11613 2008 10.1073/pnas.0801763105 Gratton SE, Ropp PA, Pohlhaus PD, Luft JC, Madden VJ, Napier ME, DeSimone JM (2008) The effect of particle design on cellular internalization pathways. Proc Natl Acad Sci USA 105:11613-11618 

   상세보기

8. Cell D Hanahan 144 646 2011 10.1016/j.cell.2011.02.013 Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646-674 

   상세보기

9. N Engl J Med FS Hodi 363 711 2010 10.1056/NEJMoa1003466 Hodi FS, O’Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB, Gonzalez R, Robert C, Schadendorf D, Hassel JC, Akerley W, van den Eertwegh AJ, Lutzky J, Lorigan P, Vaubel JM, Linette GP, Hogg D, Ottensmeier CH, Lebbe C, Peschel C, Quirt I, Clark JI, Wolchok JD, Weber JS, Tian J, Yellin MJ, Nichol GM, Hoos A, Urba WJ (2010) Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 363:711-723 

   상세보기

10. Macromol Biosci HE Jang 2016 10.1002/mabi.201600195 Jang HE, Mok H (2016) Polydopamine-coated porous microspheres conjugated with immune stimulators for enhanced cytokine induction in macrophages. Macromol Biosci. doi: 10.1002/mabi.201600195 

    상세보기

11. Cancer Immunol Res L Jeanbart 2 436 2014 10.1158/2326-6066.CIR-14-0019-T Jeanbart L, Ballester M, de Titta A, Corthesy P, Romero P, Hubbell JA, Swartz MA (2014) Enhancing efficacy of anticancer vaccines by targeted delivery to tumor-draining lymph nodes. Cancer Immunol Res 2:436-447 

    상세보기

12. Proc Natl Acad Sci USA CM Jewell 108 15745 2011 10.1073/pnas.1105200108 Jewell CM, Lopez SC, Irvine DJ (2011) In situ engineering of the lymph node microenvironment via intranodal injection of adjuvant-releasing polymer particles. Proc Natl Acad Sci USA 108:15745-15750 

    상세보기

13. Macromol Biosci H Jung 16 748 2016 10.1002/mabi.201500381 Jung H, Mok H (2016) Mixed micelles for targeted and efficient doxorubicin delivery to multidrug-resistant breast cancer cells. Macromol Biosci 16:748-758 

    상세보기

14. Blood JA Kim 116 1623 2010 10.1182/blood-2009-08-237040 Kim JA, March K, Chae HD, Johnstone B, Park SJ, Cook T, Merfeld-Clauss S, Broxmeyer HE (2010) Muscle-derived Gr1(dim)CD11b(+) cells enhance neovascularization in an ischemic hind limb mouse model. Blood 116:1623-1626 

    상세보기

15. Nature Y Kojima 536 86 2016 10.1038/nature18935 Kojima Y, Volkmer JP, McKenna K, Civelek M, Lusis AJ, Miller CL, Direnzo D, Nanda V, Ye J, Connolly AJ, Schadt EE, Quertermous T, Betancur P, Maegdefessel L, Matic LP, Hedin U, Weissman IL, Leeper NJ (2016) CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis. Nature 536:86-90 

    상세보기

16. Curr Opin Biotechnol ST Koshy 40 1 2016 10.1016/j.copbio.2016.02.001 Koshy ST, Mooney DJ (2016) Biomaterials for enhancing anti-cancer immunity. Curr Opin Biotechnol 40:1-8 

    상세보기

17. J Control Release YH Lee 199 98 2015 10.1016/j.jconrel.2014.12.007 Lee YH, Yoon HY, Shin JM, Saravanakumar G, Noh KH, Song KH, Jeon JH, Kim DW, Lee KM, Kim K, Kwon IC, Park JH, Kim TW (2015) A polymeric conjugate foreignizing tumor cells for targeted immunotherapy in vivo. J Control Release 199:98-105 

    상세보기

18. Acta Biomater E Lee 29 271 2016 10.1016/j.actbio.2015.10.025 Lee E, Jang HE, Kang YY, Kim J, Ahn JH, Mok H (2016) Submicron-sized hydrogels incorporating cyclic dinucleotides for selective delivery and elevated cytokine release in macrophages. Acta Biomater 29:271-281 

    상세보기

19. J Control Release SY Li 231 17 2016 10.1016/j.jconrel.2016.01.044 Li SY, Liu Y, Xu CF, Shen S, Sun R, Du XJ, Xia JX, Zhu YH, Wang J (2016a) Restoring anti-tumor functions of T cells via nanoparticle-mediated immune checkpoint modulation. J Control Release 231:17-28 

    상세보기

20. Oncoimmunology Y Li 5 e1074374 2016 10.1080/2162402X.2015.1074374 Li Y, Fang M, Zhang J, Wang J, Song Y, Shi J, Li W, Wu G, Ren J, Wang Z, Zou W, Wang L (2016b) Hydrogel dual delivered celecoxib and anti-PD-1 synergistically improve antitumor immunity. Oncoimmunology 5:e1074374 

    

21. Nature H Liu 507 519 2014 10.1038/nature12978 Liu H, Moynihan KD, Zheng Y, Szeto GL, Li AV, Huang B, Van Egeren DS, Park C, Irvine DJ (2014) Structure-based programming of lymph-node targeting in molecular vaccines. Nature 507:519-522 

    상세보기

22. Biomacromolecules IJ Majoros 7 572 2006 10.1021/bm0506142 Majoros IJ, Myc A, Thomas T, Mehta CB, Baker JR (2006) PAMAM dendrimer-based multifunctional conjugate for cancer therapy: synthesis, characterization, and functionality. Biomacromolecules 7:572-579 

    상세보기

23. Eur J Immunol V Manolova 38 1404 2008 10.1002/eji.200737984 Manolova V, Flace A, Bauer M, Schwarz K, Saudan P, Bachmann MF (2008) Nanoparticles target distinct dendritic cell populations according to their size. Eur J Immunol 38:1404-1413 

    상세보기

24. Scand J Immunol S Mia 79 305 2014 10.1111/sji.12162 Mia S, Warnecke A, Zhang XM, Malmstrom V, Harris RA (2014) An optimized protocol for human M2 macrophages using M-CSF and IL-4/IL-10/TGF-beta yields a dominant immunosuppressive phenotype. Scand J Immunol 79:305-314 

    상세보기

25. Expert Opin Drug Deliv H Mok 10 73 2013 10.1517/17425247.2013.747507 Mok H, Zhang MQ (2013) Superparamagnetic iron oxide nanoparticle-based delivery systems for biotherapeutics. Expert Opin Drug Deliv 10:73-87 

    상세보기

26. Mol Pharm SN Mueller 12 1356 2015 10.1021/mp500589c Mueller SN, Tian S, DeSimone JM (2015) Rapid and persistent delivery of antigen by lymph node targeting print nanoparticle vaccine carrier to promote humoral immunity. Mol Pharm 12:1356-1365 

    상세보기

27. Proc Natl Acad Sci USA N Murthy 100 4995 2003 10.1073/pnas.0930644100 Murthy N, Xu M, Schuck S, Kunisawa J, Shastri N, Frechet JM (2003) A macromolecular delivery vehicle for protein-based vaccines: acid-degradable protein-loaded microgels. Proc Natl Acad Sci USA 100:4995-5000 

    상세보기

28. Theranostics SK Patel 5 150 2015 10.7150/thno.9476 Patel SK, Janjic JM (2015) Macrophage targeted theranostics as personalized nanomedicine strategies for inflammatory diseases. Theranostics 5:150-172 

    상세보기

29. Drugs RM Poole 74 1973 2014 10.1007/s40265-014-0314-5 Poole RM (2014) Pembrolizumab: first global approval. Drugs 74:1973-1981 

    상세보기

30. Proc Natl Acad Sci USA FA Sharp 106 870 2009 10.1073/pnas.0804897106 Sharp FA, Ruane D, Claass B, Creagh E, Harris J, Malyala P, Singh M, O’Hagan DT, Petrilli V, Tschopp J, O’Neill LA, Lavelle EC (2009) Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome. Proc Natl Acad Sci USA 106:870-875 

    상세보기

31. Proc Natl Acad Sci USA J Stagg 108 7142 2011 10.1073/pnas.1016569108 Stagg J, Loi S, Divisekera U, Ngiow SF, Duret H, Yagita H, Teng MW, Smyth MJ (2011) Anti-ErbB-2 mAb therapy requires type I and II interferons and synergizes with anti-PD-1 or anti-CD137 mAb therapy. Proc Natl Acad Sci USA 108:7142-7147 

    상세보기

32. Nat Biotechnol SB Stephan 33 97 2015 10.1038/nbt.3104 Stephan SB, Taber AM, Jileaeva I, Pegues EP, Sentman CL, Stephan MT (2015) Biopolymer implants enhance the efficacy of adoptive T-cell therapy. Nat Biotechnol 33:97-101 

    상세보기

33. Theranostics X Sun 5 597 2015 10.7150/thno.11546 Sun X, Gao D, Gao L, Zhang C, Yu X, Jia B, Wang F, Liu Z (2015) Molecular imaging of tumor-infiltrating macrophages in a preclinical mouse model of breast cancer. Theranostics 5:597-608 

    상세보기

34. Nat Rev Cancer MA Swartz 12 210 2012 10.1038/nrc3186 Swartz MA, Lund AW (2012) Opinion lymphatic and interstitial flow in the tumour microenvironment: linking mechanobiology with immunity. Nat Rev Cancer 12:210-219 

    상세보기

35. Blood X Tai 119 5155 2012 10.1182/blood-2011-11-388918 Tai X, Van Laethem F, Pobezinsky L, Guinter T, Sharrow SO, Adams A, Granger L, Kruhlak M, Lindsten T, Thompson CB, Feigenbaum L, Singer A (2012) Basis of CTLA-4 function in regulatory and conventional CD4(+) T cells. Blood 119:5155-5163 

    상세보기

36. Immunol Rev DL Tang 249 158 2012 10.1111/j.1600-065X.2012.01146.x Tang DL, Kang R, Coyne CB, Zeh HJ, Lotze MT (2012) PAMPs and DAMPs: signal 0 s that spur autophagy and immunity. Immunol Rev 249:158-175 

    상세보기

37. Biomaterials SN Thomas 35 814 2014 10.1016/j.biomaterials.2013.10.003 Thomas SN, Vokali E, Lund AW, Hubbell JA, Swartz MA (2014) Targeting the tumor-draining lymph node with adjuvanted nanoparticles reshapes the anti-tumor immune response. Biomaterials 35:814-824 

    상세보기

38. Mol Pharm EA Vasievich 8 635 2011 10.1021/mp1004228 Vasievich EA, Huang L (2011) The suppressive tumor microenvironment: a challenge in cancer immunotherapy. Mol Pharm 8:635-641 

    상세보기

39. Int Immunopharmacol SD Wang 38 81 2016 10.1016/j.intimp.2016.05.016 Wang SD, Li HY, Li BH, Xie T, Zhu T, Sun LL, Ren HY, Ye ZM (2016) The role of CTLA-4 and PD-1 in anti-tumor immune response and their potential efficacy against osteosarcoma. Int Immunopharmacol 38:81-89 

    상세보기

40. J Clin Invest K Weiskopf 126 2610 2016 10.1172/JCI81603 Weiskopf K, Jahchan NS, Schnorr PJ, Cristea S, Ring AM, Maute RL, Volkmer AK, Volkmer JP, Liu J, Lim JS, Yang D, Seitz G, Nguyen T, Wu D, Jude K, Guerston H, Barkal A, Trapani F, George J, Poirier JT, Gardner EE, Miles LA, de Stanchina E, Lofgren SM, Vogel H, Winslow MM, Dive C, Thomas RK, Rudin CM, van de Rijn M, Majeti R, Garcia KC, Weissman IL, Sage J (2016) CD47-blocking immunotherapies stimulate macrophage-mediated destruction of small-cell lung cancer. J Clin Invest 126:2610-2620 

    상세보기

41. J Clin Invest EE West 123 2604 2013 10.1172/JCI67008 West EE, Jin HT, Rasheed AU, Penaloza-Macmaster P, Ha SJ, Tan WG, Youngblood B, Freeman GJ, Smith KA, Ahmed R (2013) PD-L1 blockade synergizes with IL-2 therapy in reinvigorating exhausted T cells. J Clin Invest 123:2604-2615 

    상세보기

42. Methods SD Xiang 40 1 2006 10.1016/j.ymeth.2006.05.016 Xiang SD, Scholzen A, Minigo G, David C, Apostolopoulos V, Mottram PL, Plebanski M (2006) Pathogen recognition and development of particulate vaccines: does size matter? Methods 40:1-9 

    상세보기

43. J Control Release Z Xu 172 259 2013 10.1016/j.jconrel.2013.08.021 Xu Z, Ramishetti S, Tseng YC, Guo S, Wang Y, Huang L (2013) Multifunctional nanoparticles co-delivering Trp2 peptide and CpG adjuvant induce potent cytotoxic T-lymphocyte response against melanoma and its lung metastasis. J Control Release 172:259-265 

    상세보기

44. Appl Biol Chem G Yu 59 71 2016 10.1007/s13765-015-0141-8 Yu G, Jung H, Mok H (2016) Indocyanine green-incorporated exosomes for improved in vivo imaging of sentinel lymph node. Appl Biol Chem 59:71-76 

    상세보기

45. J Immunol Y Zheng 172 2778 2004 10.4049/jimmunol.172.5.2778 Zheng Y, Manzotti CN, Liu M, Burke F, Mead KI, Sansom DM (2004) CD86 and CD80 differentially modulate the suppressive function of human regulatory T cells. J Immunol 172:2778-2784 

    상세보기

46. J Am Soc Nephrol Y Zhuang 159 135 2012 Zhuang Y, Ma Y, Wang C, Hai L, Yan C, Zhang Y, Liu F, Cai L (2012) PEGylated cationic liposomes robustly augment vaccine-induced immune responses: role of lymphatic trafficking and biodistribution. J Am Soc Nephrol 159:135-142 

47. Nat Rev Immunol W Zou 8 467 2008 10.1038/nri2326 Zou W, Chen L (2008) Inhibitory B7-family molecules in the tumour microenvironment. Nat Rev Immunol 8:467-477 

    상세보기